Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Lemos
Psy63 - Cost by Outcomes Analysis of Novel Triple-Combination Therapies for Relapsed/Refractory Multiple Myeloma in Brazil
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Effects of Selected Brominated and Chlorinated Chemicals onPseudomonas fluorescensPlanktonic Cells and Flow-Generated Biofilms
Journal of Food Processing and Preservation
Chemistry
Chemical Engineering
Food Science
Related publications
Pcn311 - European Market Access Challenges for Relapsed Refractory Multiple Myeloma Triplet Therapies
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Daratumumab vs. Pomalidomide for the Treatment of Relapsed/Refractory Multiple Myeloma: A Cost‐effectiveness Analysis
American Journal of Hematology
Hematology
Carfilzomib for Relapsed or Refractory Multiple Myeloma
The Lancet Oncology
Oncology
Comparative Analysis of Targeted Novel Therapies in Relapsed, Refractory Chronic Lymphocytic Leukaemia
Haematologica
Hematology
Bendamustine in Patients With Relapsed or Refractory Multiple Myeloma
European Journal of Medical Research
Medicine
Correction: Management of Relapsed and Refractory Multiple Myeloma: Novel Agents, Antibodies, Immunotherapies and Beyond
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Treatment Strategies and Outcomes in Patients Treated for Relapsed Refractory Multiple Myeloma Over 3 Years: Premiere Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Low-Dose Lenalidomide and Dexamethasone Combination Treatment in Elderly Patients With Relapsed and Refractory Multiple Myeloma
Hematology
Hematology
Bendamustine, Pomalidomide, and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma
Blood Cancer Journal
Oncology
Hematology